_256_384.jpg)
Drug Approval | October 12, 2021
Covaxin for kids gets nod, final approval awaited
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
The two doses of Covaxin are likely to be administered to children with a gap of 28 days
Conventional Itraconazole mainstay drug to fight fungal infection has high result variance and low patient compliance because of dosing dependence upon food, acidic beverage and antacid consumption
The test kit uses a reagent developed using Kaneka's molecular testing-related technologies
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
The first study to investigate the safety and immunogenicity of both vaccines when co-administered compared to each vaccine administered separately in adults aged 65 years and older
This opens up a huge market for the company’s Magnezis implants in India
The company plans to expand its portfolio in regulated markets aggressively
The start-up claims in clinical trials over 90 % achieved type 2 diabetes reversal and 92 % eliminated all diabetes medication within 90 days of joining the twin service
Next-generation radiofrequency catheter offers first thermal ablation perforator treatment advancement in over 10 years
Now all districts of the country will have commissioned PSA Oxygen plants
Subscribe To Our Newsletter & Stay Updated
